Storia in 2 fonti

Novo Nordisk again raises bid in battle for obesity start-up Metsera

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs

Raccontata da

ft.com

cnbc.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

ft.comStai leggendo7 mesi fa

Novo Nordisk again raises bid in battle for obesity start-up Metsera

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs

originale

cnbc.com8 mesi fa

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.

Leggi questa versione → originale

Timeline cronologica

lunedì 3 novembre 2025·ft.com
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid
Novo and Metsera deny Pfizer’s arguments
martedì 4 novembre 2025·ft.com
Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies
Improved pitches from both large pharma groups expected to be revealed later on Tuesday

Novo Nordisk again raises bid in battle for obesity start-up Metsera

Confronto fonti

Novo Nordisk again raises bid in battle for obesity start-up Metsera

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

Timeline cronologica

Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid

Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk

Novo Nordisk loses further ground in obesity market

There is only one winner in the Pfizer Novo Nordisk showdown

US regulator warns Novo Nordisk’s Metsera offer ‘may violate’ antitrust law

Novo Nordisk again raises bid in battle for obesity start-up Metsera

US to slash prices of obesity drugs offered on Trump website

Pfizer wins $10bn bidding war for weight-loss start-up Metsera